Elutia Inc. (ELUT)

4.4000 -0.2800 (-5.98%) At close: 04:00PM EDT

Elutia Inc.

12510 Prosperity Drive
Suite 370
Silver Spring, MD 20904
United States
240 247 1170
https://elutia.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 54

Key executives

Name	Title	Pay	Exercised	Year born
Dr. C. Randal Mills Ph.D.	Co-Founder, President & CEO and Director	965.42k	N/A	1972
Mr. Matthew B. Ferguson	Chief Financial Officer	521.08k	N/A	1968
Dr. Michelle LeRoux Williams Ph.D.	Chief Scientific Officer	485.97k	N/A	1975
Ms. Erica Elchin	Vice President of Global Operations	N/A	N/A	N/A
Ms. Courtney Guyer	Vice President of Marketing	N/A	N/A	N/A
Dr. Sonali Fonseca Ph.D.	VP & Head of Emerging Businesses	N/A	N/A	N/A
Mr. Jeffry D. Hamet	Senior VP of Finance, Treasurer & Secretary	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Elutia Inc., a commercial-stage company, develops and commercializes drug-eluting biologics products for neurostimulation, wound care, and breast reconstruction in the United States. The company operates in three segments: Device Protection; Women's Health; and Cardiovascular. It offers CanGaroo Envelope, which is used to accommodate cardiac implantable electronic devices, such as pacemakers and internal defibrillators. The company also develops CanGarooRM, a combination of the CanGaroo envelope with antibiotics, to reduce the risk of infection after surgical implantation of an electronic device. In addition, it provides ProxiCor for cardiac tissue repair and pericardial closure; Tyke, an extracellular material that is used in the repair of cardiac structures for neonate and infant patients; and VasCure, a patch material to repair or reconstruct the peripheral vasculature. Further, the company offers SimpliDerm, which uses human acellular dermal matrices for tissue repair and reconstruction in various applications, such as sports medicine, hernia repair, trauma reconstruction, and breast reconstruction surgeries following mastectomy. It serves hospitals and healthcare facilities through its direct sales force, independent sales agents, and distributors. The company was formerly known as Aziyo Biologics, Inc. and changed its name to Elutia Inc. in September 2023. Elutia Inc. was incorporated in 2015 and is headquartered in Silver Spring, Maryland.

Corporate governance

Elutia Inc.’s ISS governance QualityScore as of 1 July 2024 is 8. The pillar scores are Audit: 4; Board: 4; Shareholder rights: 8; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.